tiprankstipranks
Trending News
More News >
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
US Market

MapLight Therapeutics, Inc. (MPLT) Financial Statements

Compare
10 Followers

MapLight Therapeutics, Inc. Financial Overview

MapLight Therapeutics, Inc.'s market cap is currently $817.17M. The company's EPS TTM is $; its P/E ratio is ―; MapLight Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -701.00K$ -556.00K$ -574.00K
Operating Income$ -82.95M$ -57.28M$ -31.25M
EBITDA$ -76.88M$ -55.15M$ -29.44M
Net Income$ -77.58M$ -55.71M$ -30.02M
Balance Sheet
Cash & Short-Term Investments$ 108.80M$ 79.77M$ 27.66M
Total Assets$ 136.92M$ 91.41M$ 39.39M
Total Debt$ 6.58M$ 5.92M$ 6.27M
Net Debt$ -31.67M$ -73.84M$ -21.39M
Total Liabilities$ 21.72M$ 20.13M$ 18.52M
Stockholders' Equity$ 115.19M$ 71.28M$ 20.87M
Cash Flow
Free Cash Flow$ -79.58M$ -52.47M$ -27.32M
Operating Cash Flow$ -78.81M$ -52.01M$ -26.58M
Investing Cash Flow$ -80.79M$ -462.00K$ -746.00K
Financing Cash Flow$ 118.06M$ 104.57M$ 33.17M
Currency in USD

MapLight Therapeutics, Inc. Earnings and Revenue History

MapLight Therapeutics, Inc. Debt to Assets

MapLight Therapeutics, Inc. Cash Flow

MapLight Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.